A deficient TAA, low MHC presentation of antigenic material, T cell/ DC interactions abnormal vasculature and immune suppressive TME, all contribute to defective priming/homing mechanisms in these types of tumor [28].  Thus treatment methods which could turn these unfavorable conditions to favorable ones are being explored. The gene discussed is HLA-C; the disease is neoplasm.